Table 1 Patient characteristics.

From: Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia

 

Brazil

China

Ethiopia

LL/BL

30 (31%)

47 (76%)

17 (71%)

BT/TT

41 (42%)

10 (16%)

4 (17%)

Others*

26 (27%)

5 (8%)

3 (12.5%)

age (median (min-max)) years

39.5 (8–78)

35 (13–72)

29 (6–75)

male/ female

52/45

40/18

17/7

Prevalence (per 10,000)

NA

0.085 (Qianxinan) 0.011 (Guiyang)

0.32

New case detection rate (per 100,000)

30.4

NA

NA

  1. Patient characteristics of the Brazilian, Chinese and Ethiopian test cohorts. Patients were stratified by clinical form based on Ridley-Jopling classification. The number of lepromatous leprosy (LL)/borderline lepromatous (BL) and borderline tuberculoid (BT)/tuberculoid (TT) patients are indicated for each group. *Patients that were not classified in one of these two groups (borderline, indeterminate, neural leprosy or not assessed) are referred to as others. The prevalence or new case detection rate is region specific.